Company: SXTPW
Filing Date: 2025-01-30
Form Type: 424B5
Source: 0001213900-25-008098
Chunk: 12

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-01-30
Form: 424B5
Chunk 12
---
ouza et al Biology of Blood and Bone Marrow Transplantation 202;26: e177-e182; See statistics for acute          
 lymphoblastic leukemia at: Key Statistics for Acute Lymphocytic Leukemia (ALL) (cancer.org); See statistics for large cell large           
 B-cell lymphoma at; Diffuse Large B-Cell Lymphoma - Lymphoma Research Foundation; Treatment guidelines recommending antifungal prophylaxis 
 for these diseases can be reviewed in (i) Fishman et al Clinical Transplantation. 2019;33:e13587, (ii) Hematopoietic Cell Transplantation  
 (cancernetwork.com), (iii) Cooper et al Journal of the National Comprehensive Cancer Network 2016;14:882-913 and (iv) Los Arcos et         
 al Infection (2021) 49:215–231.                                                                                                            |

| 18 | Aguilar-Guisado                                                     
 et al Clin Transplant 2011;25:E629–38; Mace et al MMWR 202;70:1–35. |

| 19 | Queener                                                                        
 et al JID 1997;165:764-768; Dow and Smith New Microb New Infect 2022;45:100964 |

| 20 | https://www.ecdc.europa.eu/en/dengue-monthly#:~:text=This%20is%20an%20increase%20of%2032%20653%20cases% 20and%2032,853%20deaths%20have%20been%20reported. |

| 21 | https://www.cdc.gov/rsv/php/surveillance/index.html#cdc_survey_profile_surveys_used-rsv-burden-estimates. |

| 22 | In 2014, we signed a cooperative                                                                                                     
 research and development agreement with the United States Army Medical and Materiel Development Activity (Agreement W81XWH-14-0313). 
 Under this agreement, we agreed to submit an NDA for Tafenoquine to the FDA (as Arakoda), while the US Army agreed to finance the    
 bulk of the necessary development activities in support of that goal.                                                                |

| 23 | Zottig                                       
 et al Military Medicine 2020; 185 (S1): 687. |

<div align='center'>S-4</div>

The FDA and Australia’s medicinal